A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence

Schizophrenia Research

Volumn 152, Issue 1, 2014, Pages 139-145

  Khandaker, Golam M ^a,b,c   Zammit, Stanley ^c,d   Lewis, Glyn ^c,e   Jones, Peter B ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adolescence; ALSPAC; Asthma; Atopic disorders; Birth cohort; Childhood; CRP; Cytokine; Eczema; IL 6; Immunity; Inflammatory markers; Prospective study; Psychotic experiences; Psychotic symptoms; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INFLAMMATORY MARKER; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT; AGE; ARTICLE; ASTHMA; ATOPY; BODY MASS; CHILD; CHILDHOOD; CONTROLLED STUDY; ECZEMA; ETHNICITY; EXPERIENCE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCHIZOPHRENIA; SCHOOL CHILD; SOCIAL CLASS;

95% CONFIDENCE INTERVAL; ADOLESCENCE; ALSPAC; ASTHMA; ATOPIC DISORDERS; BIRTH COHORT; C-REACTIVE PROTEIN; CHILDHOOD; CI; CRP; CYTOKINE; ECZEMA; IL-6; IMMUNITY; INFLAMMATORY MARKERS; INTERLEUKIN 6; ODDS RATIO, 95%; OR; PES; PROSPECTIVE STUDY; PSYCHOTIC EXPERIENCES; PSYCHOTIC SYMPTOMS; SCHIZOPHRENIA;

ADOLESCENT; ASTHMA; C-REACTIVE PROTEIN; CHILD; COMMUNITY HEALTH PLANNING; DISEASE PROGRESSION; ECZEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES;

EID: 84891619328     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.09.021     Document Type: Article

References (60)

1. Akhabir L., Sandford A.J. Genome-wide association studies for discovery of genes involved in asthma. Respirology 2011, 16(3):396-406.
2. Anon Classification of occupations and coding index. Office of Population Censuses and Surveys 1980, x. Her Majesty's Stationery Office, London, (http://www.ons.gov.uk/ons/guide-method/classifications/archived-standard-classifications/soc-and-sec-archive/index.html).
3. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
4. Bevan Jones R., Thapar A., Lewis G., Zammit S. The association between early autistic traits and psychotic experiences in adolescence. Schizophr. Res. 2012, 135(1-3):164-169.
5. Boulay M.E., Boulet L.P. The relationships between atopy, rhinitis and asthma: pathophysiological considerations. Curr. Opin. Allergy Clin. Immunol. 2003, 3(1):51-55.
6. Boyd A., Golding J., Macleod J., Lawlor D.A., Fraser A., Henderson J., Molloy L., Ness A., Ring S., Davey Smith G. Cohort profile: the 'Children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 2013, 42(1):111-127.
7. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280.
8. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61(8):774-780.
9. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., Perrin M., Gorman J.M., Susser E.S. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2004, 161(5):889-895.
10. Brown A.S., Schaefer C.A., Quesenberry C.P., Liu L., Babulas V.P., Susser E.S. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry 2005, 162(4):767-773.
11. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 2001, 58(11):1032-1037.
12. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav. Immun. 2001, 15(4):411-420.
13. Chen Y.H., Lee H.C., Lin H.C. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr. Res. 2009, 108(1-3):191-196.
14. Chen S.J., Chao Y.L., Chen C.Y., Chang C.M., Wu E.C., Wu C.S., Yeh H.H., Chen C.H., Tsai H.J. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry J. Ment. Sci. 2012, 200(5):374-380.
15. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165(1):59-65.
16. de Jager W., Bourcier K., Rijkers G.T., Prakken B.J., Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009, 10:52.
17. De Loore E., Gunther N., Drukker M., Feron F., Sabbe B., Deboutte D., van Os J., Myin-Germeys I. Persistence and outcome of auditory hallucinations in adolescence: a longitudinal general population study of 1800 individuals. Schizophr. Res. 2011, 127(1-3):252-256.
18. Delisi L.E., Smith S.B., Hamovit J.R., Maxwell M.E., Goldin L.R., Dingman C.W., Gershon E.S. Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 1986, 16(4):757-763.
19. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163(3):521-528.
20. Falaschetti E., Hingorani A.D., Jones A., Charakida M., Finer N., Whincup P., Lawlor D.A., Davey Smith G., Sattar N., Deanfield J.E. Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. Eur. Heart J. 2010, 31(24):3063-3072.
21. Fraser A., Macdonald-Wallis C., Tilling K., Boyd A., Golding J., Davey Smith G., Henderson J., Macleod J., Molloy L., Ness A., Ring S., Nelson S.M., Lawlor D.A. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int. J. Epidemiol. 2013, 42(1):97-110.
22. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60(2):132-140.
23. Holland N.T., Smith M.T., Eskenazi B., Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat. Res. 2003, 543(3):217-234.
24. Horwood J., Salvi G., Thomas K., Duffy L., Gunnell D., Hollis C., Lewis G., Menezes P., Thompson A., Wolke D., Zammit S., Harrison G. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br. J. Psychiatry J. Ment. Sci. 2008, 193(3):185-191.
25. 18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophr. Bull. 2013, 39(4):807-814.
26. Janeway C.A., Travers P., Walport M., Shlomchik M.J. Immunobiology: The Immune System in Health and Disease 2001, Garland Science, New York. 5th ed.
27. Judd C.M., Kenny D.A. Process analysis: estimating mediation in treatment evaluations. Eval. Rev. 1981, 5(5):602-619.
28. Kaur B., Anderson H.R., Austin J., Burr M., Harkins L.S., Strachan D.P., Warner J.O. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). BMJ 1998, 316(7125):118-124.
29. Kelleher I., Cannon M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol. Med. 2011, 41(1):1-6.
30. Khandaker G.M., Zimbron J., Dalman C., Lewis G., Jones P.B. Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr. Res. 2012, 139(1-3):161-168.
31. Khandaker G.M., Zimbron J., Lewis G., Jones P.B. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol. Med. 2012, 1-19.
32. Lai C.K., Beasley R., Crane J., Foliaki S., Shah J., Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009, 64(6):476-483. International Study of, A., Allergies in Childhood Phase Three Study, G.
33. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90(3):285-326.
34. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
35. Miller B.J., Culpepper N., Rapaport M.H. C-reactive protein levels in schizophrenia. Clin. Schizophr. Relat. Psychoses 2013, 1-22.
36. Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., Depner M., von Berg A., Bufe A., Rietschel E., Heinzmann A., Simma B., Frischer T., Willis-Owen S.A., Wong K.C., Illig T., Vogelberg C., Weiland S.K., von Mutius E., Abecasis G.R., Farrall M., Gut I.G., Lathrop G.M., Cookson W.O. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448(7152):470-473.
37. Mortensen P.B., Norgaard-Pedersen B., Waltoft B.L., Sorensen T.L., Hougaard D., Torrey E.F., Yolken R.H. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol. Psychiatry 2007, 61(5):688-693.
38. Mortensen P.B., Pedersen C.B., Hougaard D.M., Norgaard-Petersen B., Mors O., Borglum A.D., Yolken R.H. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr. Res. 2010, 122(1-3):257-263.
39. Murray G.K., Jones P.B. Psychotic symptoms in young people without psychotic illness: mechanisms and meaning. Br. J. Psychiatry J. Ment. Sci. 2012, 201(1):4-6.
40. Pedersen M.S., Benros M.E., Agerbo E., Borglum A.D., Mortensen P.B. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr. Res. 2012, 138(1):58-62.
41. Poulton R., Caspi A., Moffitt T.E., Cannon M., Murray R., Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch. Gen. Psychiatry 2000, 57(11):1053-1058.
42. Rantakallio P., Jones P., Moring J., Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int. J. Epidemiol. 1997, 26(4):837-843.
43. Rothermundt M., Arolt V., Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 2001, 15(4):319-339.
44. Rottem M., Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int. Arch. Allergy Immunol. 2003, 132(3):210-214.
45. Rubio J.M., Sanjuan J., Florez-Salamanca L., Cuesta M.J. Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr. Res. 2012, 138(2-3):248-254.
46. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813(5):878-888.
47. Shaffer D., Fisher P., Lucas C.P., Dulcan M.K., Schwab-Stone M.E. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(1):28-38.
48. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
49. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. Off. J. Soc. Neurosci. 2007, 27(40):10695-10702.
50. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747.
51. Thomas K., Harrison G., Zammit S., Lewis G., Horwood J., Heron J., Hollis C., Wolke D., Thompson A., Gunnell D. Association of measures of fetal and childhood growth with non-clinical psychotic symptoms in 12-year-olds: the ALSPAC cohort. Br. J. Psychiatry J. Ment. Sci. 2009, 194(6):521-526.
52. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38(3):642-647.
53. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39(2):179-195.
54. Wang H., Yolken R.H., Hoekstra P.J., Burger H., Klein H.C. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study. Schizophr. Res. 2011, 129(1):47-51.
55. Weber N.S., Cowan D.N., Millikan A.M., Niebuhr D.W. Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr. Serv. 2009, 60(8):1059-1067.
56. Weizman R., Bessler H. Cytokines: Stress and Immunity 1999, CRC Press.
57. WHO SCAN: Schedules for Clinical Assessment in Neuropsychiatry Version 2.0 1994, Psychiatric Publishers International/American Psychiatric Press Inc., Geneva, Switzerland.
58. Zammit S., Odd D., Horwood J., Thompson A., Thomas K., Menezes P., Gunnell D., Hollis C., Wolke D., Lewis G., Harrison G. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12years in the ALSPAC birth cohort. Psychol. Med. 2009, 39(9):1457-1467.
59. Zammit S., Kounali D., Cannon M., David A.S., Gunnell D., Heron J., Jones P.B., Lewis S., Sullivan S., Wolke D., Lewis G. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am. J. Psychiatry 2013, 170(7):742-750.
60. Zandi M.S., Irani S.R., Lang B., Waters P., Jones P.B., McKenna P., Coles A.J., Vincent A., Lennox B.R. Disease-relevant autoantibodies in first episode schizophrenia. J. Neurol. 2011, 258(4):686-688.